ID

27678

Description

Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML) - NCT01488344 https://clinicaltrials.gov/ct2/show/NCT01488344 Principal Investigator PD Dr. Utz Krug RATIONALE: Low-dose cytarabine works in a minority of elderly patients with an acute myeloid leukemia unfit for intensive induction therapy by killing of leukemia cells. Addition of BIBF1120 to low-dose cytarabine might enhance the killing of leukemia cells. PURPOSE: This phase I / II trial is studying how safe BIBF1120 can be combined with low-dose cytarabine (phase I) and how well the combination of low-dose cytarabine and BIBF1120 works in elderly patients with acute myeloid leukemia unfit for intensive chemotherapy (phase II). Study Type: Interventional Study Design: Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: A Single-arm, Open Label, Multi-center Phase I/II Trial to Assess the Safety and Efficacy of BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With AML Unfit for an Intensive Induction Therapy

Lien

https://clinicaltrials.gov/ct2/show/NCT01488344

Mots-clés

Versions (1)
  1. 26/11/2017 26/11/2017 -
Détendeur de droits

PD Dr. Utz Krug

Téléchargé le

26 novembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With AML NCT01488344

Allemand ( localization.languageCode.DE )

Withdrawal from study

1 Formulaires  
  1. StudyEvent: ODM
    1. Withdrawal from study
Studienabbruch
Description

Studienabbruch

Alias
UMLS CUI-1
C0422727
Vorzeitiger Studienabbruch am
Description

Date of withdrawal from study

Type de données

date

Alias
UMLS CUI [1,1]
C0444496
UMLS CUI [1,2]
C0011008
Primärer Grund
Description

Reason for study withdrawal

Type de données

integer

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
AE-Nr.:
Description

Adverse event code

Type de données

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0805701
UMLS CUI [1,3]
C1521902
Rezidiv am:
Description

Date of relapse

Type de données

date

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C0011008
Art des Rezidivs:
Description

AML Type of relapse

Type de données

integer

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0205336
Art des extramedullären Rezidives
Description

Extramedullary relapse

Type de données

integer

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0035020
UMLS CUI [1,3]
C1517060
Andere extramedulläre Rezidivlokalisation
Description

Other extramedullary relapse manifestation

Type de données

text

Alias
UMLS CUI [1,1]
C1868812
UMLS CUI [1,2]
C1521902
Tod am:
Description

Date of death

Type de données

date

Alias
UMLS CUI [1]
C1148348
Anderer Grund:
Description

Other reason for withdrawal

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C3840932
Unterschrift
Description

Unterschrift

Alias
UMLS CUI-1
C2346576
Datum
Description

Date of investigator signature

Type de données

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Name
Description

Investigator name

Type de données

text

Alias
UMLS CUI [1]
C2826892
Unterschrift
Description

Investigator signature

Type de données

text

Alias
UMLS CUI [1]
C2346576
Retour au début de la page

Similar models

Withdrawal from study

1 Formulaires
  1. StudyEvent: ODM
    1. Withdrawal from study
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Studienabbruch
C0422727 (UMLS CUI-1)
Date of withdrawal from study
Item
Vorzeitiger Studienabbruch am
date
C0444496 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Primärer Grund
integer
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Reason for study withdrawal
Code List
Primärer Grund
CL Item
Unerwünschte(s) Ereignis(se) (1)
CL Item
Erkrankungsprogression (2)
CL Item
primär refraktär nach 6 Therapiezyklen (3)
CL Item
Rezidiv am: (4)
CL Item
Tod am: (5)
CL Item
Einverständnis entzogen (6)
CL Item
Fehlende Compliance (7)
CL Item
Anderer Grund (8)
Adverse event code
Item
AE-Nr.:
text
C0877248 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Date of relapse
Item
Rezidiv am:
date
C0035020 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Art des Rezidivs:
integer
C0023467 (UMLS CUI [1,1])
C0205336 (UMLS CUI [1,2])
AML Type of relapse
Code List
Art des Rezidivs:
CL Item
Knochenmark  (1)
CL Item
extramedullär (2)
Item
Art des extramedullären Rezidives
integer
C0023467 (UMLS CUI [1,1])
C0035020 (UMLS CUI [1,2])
C1517060 (UMLS CUI [1,3])
Extramedullary relapse
Code List
Art des extramedullären Rezidives
CL Item
ZNS (1)
CL Item
andere (2)
Other extramedullary relapse manifestation
Item
Andere extramedulläre Rezidivlokalisation
text
C1868812 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
Date of death
Item
Tod am:
date
C1148348 (UMLS CUI [1])
Other reason for withdrawal
Item
Anderer Grund:
text
C0422727 (UMLS CUI [1,1])
C3840932 (UMLS CUI [1,2])
Item Group
Unterschrift
C2346576 (UMLS CUI-1)
Date of investigator signature
Item
Datum
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Investigator name
Item
Name
text
C2826892 (UMLS CUI [1])
Investigator signature
Item
Unterschrift
text
C2346576 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial